Ferment - Annual Biotechnology Conference

PERFORMANCES  •  COCKTAILS  •  PANEL DISCUSSIONS  •  DEVELOPER TALKS  •  PRODUCT DEMOS  •  PERFORMANCES  •  COCKTAILS  •  PANEL DISCUSSIONS  •  DEVELOPER TALKS  •  PRODUCT DEMOS  •  
PERFORMANCES  •  COCKTAILS  •  PANEL DISCUSSIONS  •  DEVELOPER TALKS  •  PRODUCT DEMOS  •  PERFORMANCES  •  COCKTAILS  •  PANEL DISCUSSIONS  •  DEVELOPER TALKS  •  PRODUCT DEMOS  •  
audience photo from Ginkgo Ferment 2023 during talk titled "Catalyzing Innovation in Health and Medicine"
GINKGO BIOWORKS PRESENTS

Ferment 2024

Thursday April 11th, 2024 8am – 7pm ET

SoWa Power Station | Boston, MA

Register

Experience our platform

Join us for a day of talks, takes, demos, and data by the petabyte: Ginkgo style.

Hear from developers on the newest synthetic biology applications; learn the latest AI & ML developments in programming biology; see exclusive demos from our Foundry and Automation teams; and engage with industry leaders influencing the R&D renaissance. Experience the convening power of our ecosystem and cultivate new connections and collaborations that strengthen your industry.

photo of large, inflatable art installation at ferment 2023, attendees sit inside and chat
photo of abstract art installation at ferment 2023
photo of audience at Ginkgo Ferment 2023 conference
photo of light installation at ferment 2023 conference, the lights are designed to look like molecules
photo of 'revolution' exhibit at ferment synthetic biology conference

Calling all cell developers

Discover how our partners apply biology across industries

photo from inside endoplasmic reticulum-inspired art installation from Ginkgo Ferment 2023 conference
RUN OF SHOW

Agenda

Panels, Lightning Talks, and Platform Presentations

Time
Event
Speakers
Type
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
8:00 am
Doors Open
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
Check in, Breakfast, Networking

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
9:30 am
Welcome Keynote
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
Chief Executive Officer of Ginkgo Bioworks

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
9:55 am
Data is Queen: Biopharma & AI
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
10:15 am
Application Lightning Talks
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
10:30 am
Break & Networking
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
11:00 am
Platform Presentation
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
Biosecurity

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
11:15 am
Global Biosecurity
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
11:30 am
Application Lightning Talks
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
12:00 pm
Lunch
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
1:30 pm
Platform Presentation
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
1:40 pm
The State of Biopharma R&D
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
Challenges, Opportunities & Trends

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
2:10 pm
Application Lightning Talks
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
2:20 pm
Break & Networking
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
3:20 pm
To Be Announced
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
3:40 pm
Application Lightning Talks
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
To be announced

Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS
5:00 pm
Cocktail Party
No items found.
Keynote
PLATFORM PRESENTATION
PANEL
LIGHTNING TALKS

photo of presenter at Ginkgo Ferment 2023 conference. projected behind her is an illustration of earth from space
PROGRAM

Speakers

Eyal Afergan
Eyal Afergan
Co-Founder & Chief Executive Officer, ImaginDairy
Eyal Afergan
Co-Founder & Chief Executive Officer, ImaginDairy
Learn More

Eyal Afergan is Co-Founder and CEO of ImaginDairy, a food-tech startup that is trailblazing a new future for the dairy industry by producing sustainable, animal-free dairy proteins via precision fermentation. With extensive experience in executive roles for biotechnology companies like Enzymotec and Algatechnologies, Eyal brings his wide-ranging education to the forefront leading the helm at ImaginDairy. His specialities in nanoscale drug delivery systems development and scale-up management skills are supported by his Ph.D in Pharmaceutics from the Hebrew University of Jerusalem and a BSc in Biochemical Engineering from Technion- Israel Institute of Technology.

Todd Beckman
Todd Beckman
Chief Executive Officer, Verb Biotics
Todd Beckman
Chief Executive Officer, Verb Biotics
Learn More

Todd Beckman leads the Verb Biotics vision and team to apply biotechnology, advanced science, and intentional development to deliver microbiome health ingredients that advance human health. He has over 30 years’ experience leading food technology and industry-disruptive consumer product brands. At Verb, his mission is to deliver function-first microbiome health solutions where consumers can truly say “I feel the effect;” moving microbiome science from labs to lives. Prior to Verb Biotics, Todd was the Co-Founder and President, COO, CEO at the well-loved probiotic drink brand, GoodBelly. In this role, he headed brand innovation, sales, and supply chain operations. Prior to launching GoodBelly, he was an integral part of the success at White Wave, where he was a key executive on the scaling of Silk Soymilk products prior to the acquisition by Dean Foods. After the acquisition, Todd was responsible for strategic planning and integration of the White Wave, Horizon Organic and Dean National brands.

Stéphane Corgié
Stéphane Corgié
Founder & Chief Executive Officer, Zymtronix
Stéphane Corgié
Founder & Chief Executive Officer, Zymtronix
Learn More

Stephane has over 20 years of academic and corporate R&D experience of environmental and industrial biotechs. During his PhD, he developed new molecular tools to optimize plant-microbe interactions applied to the biodegradation of recalcitrant pollutants like Polycyclic Aromatic Hydrocarbons (PAHs). For his postdoctoral work in the Department of Biological and Environmental Engineering at Cornell University, he developed new tools and systems ranging from the control of single molecules to industrial processes. As Founder and CEO of Zymtronix he has created the company’s core technology, directed the company’s product development, and fostered investor and corporate partnerships.

Jason Kelly
Jason Kelly
Chief Executive Officer, Ginkgo Bioworks
Jason Kelly
Chief Executive Officer, Ginkgo Bioworks
Learn More

Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Headquartered in Boston, Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. Ginkgo is listed on the New York Stock Exchange. Jason chairs the National Security Commission on Emerging Biotechnology, which evaluates how advancements in emerging biotechnology will shape current and future activities of the Department of Defense. Prior to Ginkgo, Jason received B.S. degrees in Chemical Engineering and Biology and a Ph.D. in Biological Engineering all from MIT.

Prateek Mahalwar
Prateek Mahalwar
Founder & Chief Executive Officer, BIOWEG
Prateek Mahalwar
Founder & Chief Executive Officer, BIOWEG
Learn More

Prateek serves as the Founder and CEO of BIOWEG, a pioneering company dedicated to providing the personal care and agriculture industries with ingredients free from fossil fuels, leveraging zero-waste circular methodologies, advanced fermentation techniques, innovative formulations, and the principles of green chemistry. Before establishing BIOWEG, Prateek's professional journey included a significant period in strategy consulting at EY-Parthenon. His scholarly pursuits reached a zenith with a Ph.D. from the Max Planck Institute in Germany, under the tutelage of Nobel laureate Prof. Christiane Nüsslein-Volhard.

Debora "Debbie" Marks, PhD
Debora "Debbie" Marks, PhD
Professor of Systems Biology at Harvard Medical School
Debora "Debbie" Marks, PhD
Professor of Systems Biology at Harvard Medical School
Learn More

Debora is a mathematician and computational biologist with a track record of using novel algorithms and statistics to successfully address unsolved biological problems. She has a passion for interpreting genetic variation in a way that impacts biomedical applications. During her PhD, she quantified the potential pan-genomic scope of microRNA targeting and combinatorial regulation of protein expression and co-discovered the first microRNA in a virus. As a postdoc she and her colleagues cracked the classic, unsolved problem of ab initio 3D structure prediction of proteins using a maximum entropy probability model for evolutionary sequences. She has developed this approach to determine functional interactions, biomolecular structures, including the 3D structure of RNA and RNA-protein complexes and the conformational ensembles of apparently disordered proteins. Her new lab at Harvard is interested in developing methods in deep learning to address a wide range of biological challenges including predicting the effects of genetic variation and sequence design for biosynthetic applications.

Matt McKnight
Matt McKnight
General Manager of Biosecurity, Ginkgo Bioworks
Matt McKnight
General Manager of Biosecurity, Ginkgo Bioworks
Learn More

Matt leads Biosecurity at Ginkgo Bioworks (NYSE:DNA). Biosecurity is Ginkgo's business unit focused on national security and global pandemic response. Prior to building the Biosecurity business, Matt spent 4 years as Ginkgo’s Chief Commercial Officer and 7 years as an investor at IndUS Growth Partners where he was also the President and COO of Decision Resources Group. Matt has worked supporting business development at Palantir Technologies and is an active venture investor. Early in his career, he served as an officer in the United States Marine Corps. Matt completed a degree in History at Dartmouth College and is a graduate of the joint degree program at the Harvard Business School and the Harvard Kennedy School of Government where he was a Zuckerman Fellow.

Professor Trent Munro
Professor Trent Munro
Senior VP of Therapeutics, Microba
Professor Trent Munro
Senior VP of Therapeutics, Microba
Learn More

Professor Munro has over 25 years’ research and development experience, including at Amgen where he held executive roles focussed on the translation of molecules from research, through clinical trials, regulatory approval, and global licensure. This portfolio included a diverse range of programs spanning novel biologics, small molecules, nucleic acid-based, cell-based and gene-based therapies. As Senior Vice President of Therapeutics at Microba Life Sciences, Professor Munro leads the Company’s therapeutic strategy to progress its drug development programs and pharma partnering engagements. Professor Munro completed postdoctoral studies in cell biology and developmental genetics at Harvard Medical School and the University of Cambridge and has a PhD in Protein Biochemistry from the University of Queensland.

Marcus Schindler, PhD
Marcus Schindler, PhD
Executive Vice President & Chief Scientific Officer, Novo Nordisk
Marcus Schindler, PhD
Executive Vice President & Chief Scientific Officer, Novo Nordisk
Learn More

Marcus holds a PhD in Pharmacology from the University of Cambridge (UK) and has nearly 25 years of experience in leadership roles in the pharmaceutical industry. He has worked for international large pharma and biotechnology companies, including AstraZeneca (Sweden), Boehringer Ingelheim (Germany), and (OSI) Prosidion (UK and US). He has (co-)authored more than 50 peer-reviewed research papers and is the inventor of 25 international patent applications. Marcus is also an Adjunct Professor of Pharmacology at the University of Gothenburg (Sweden). In 2018, Marcus joined Novo Nordisk as SVP for External Innovation & Strategy, and later became the lead of Global Drug Discovery. Since March 2021, he has led the Research and Early Development (R&ED) EVP area with accountability for driving scientific innovation, from idea generation to human proof-of-concept. In his current role, Marcus has transformed Novo Nordisk's drug discovery approach into a "human-centric" one across all therapy areas, from diabetes and obesity to newer areas such as cardiovascular disease (CVD), chronic kidney disease (CKD), and metabolic dysfunction- associated steatohepatitis (MASH). He has expanded the portfolio's focus on new modes of action and novel treatment modalities, including cell therapy and RNAi. Marcus places a strong emphasis on external innovation through collaborations and licensing deals. He has led the establishment of novel organizational set-ups that enable innovation, such as Transformational Research Units (TRUs), including the Cell Therapy R&D and the BioInnovation Hub in Boston. He has also initiated a set of initiatives to promote diversity and inclusion as an essential part of early research.

Anne Palermo
Anne Palermo
Co-Founder & Chief Executive Officer, Aqua Cultured Foods
Anne Palermo
Co-Founder & Chief Executive Officer, Aqua Cultured Foods
Learn More

Anne Palermo is Co-Founder & CEO, Anne is a second-time founder and passionate sustainability enthusiast that believes technology is the key to delivering a lasting impact on our global community. This mission-centric drive led her the creation of Aqua’s version 1 product and ultimately co-founding Aqua Cultured Foods, a leading future food startup in the alternative protein space. Anne is focused on using Aqua’s novel fermentation technology to bring to market a food tech platform with the ability to disrupt the traditional food manufacturing industry. Prior to co-founding Aqua, Anne had a prestigious career in banking with Morgan Stanley and BMO Capital Markets. However, she felt that she could contribute more to the world and help contribute to making it a little bit better. So, she decided to further her education in product development and culinary sciences. Upon graduation, she co-founded a consumer product goods startup in the food and beverage industry. There, she developed two types of novel and proprietary technologies centered around the commercial scale up of a healthy snacking platform. This positioned the brand favorably to capture significant traction in a market white space. Resulting in sales velocities of 10x expectations for the category. She quickly scaled the company to a multimillion dollar platform. Anne is currently a guest lecturer at Northwestern University and is a member of the Industrial Leadership Council for World Business Chicago.

Jen Wipf
Jen Wipf
Head of Commercial, Ginkgo Bioworks
Jen Wipf
Head of Commercial, Ginkgo Bioworks
Learn More

Jennifer oversees cell engineering business development activities and execution against the existing book of business, managing the intersection of commercial activity and technical progress. Her team is responsible for signing new commercial deals as well as managing relationships with existing customers, tracking progress against technical milestones, and ensuring projects are appropriately resourced. Prior to Ginkgo, Jennifer spent 13 years at Merck, where she was ultimately the Director of Strategy Realization for US Market Commercial Operations. Jennifer holds a Master’s in Chemical Engineering from Stanford University and a B.S. in Bioengineering and Biomedical Engineering from the University of Arizona.

8:00 am
Doors Open
9:30 am
Welcome Keynote
9:55 am
Data is Queen: Biopharma & AI
10:15 am
Application Lightning Talks
10:30 am
Break & Networking
11:00 am
Platform Presentation
11:15 am
Global Biosecurity
11:30 am
Application Lightning Talks
12:00 pm
Lunch
1:30 pm
Platform Presentation
1:40 pm
The State of Biopharma R&D
2:10 pm
Application Lightning Talks
2:20 pm
Break & Networking
3:20 pm
To Be Announced
3:40 pm
Application Lightning Talks
5:00 pm
Cocktail Party
TRAVELING TO BOSTON?

Hotel Blocks

We’ve reserved room blocks within walking distance of SoWa Power Station for 4/10 and 4/11.

Cambria Hotel Boston

Booking cutoff: March 11th

Booking link
AC Hotel Boston Downtown

Booking cutoff: March 11th

Booking link
WHAT IS FERMENT LIKE?

Highlight Reel

Watch Now
photo of audience at Ginkgo Ferment 2023 conference
FERMENT OVER THE YEARS

Access Past Years’ Recordings

Watch Now

FAQ

Who attends Ferment?

Ferment brings together the entire synthetic biology ecosystem: Ginkgo's community of customers, investors, academics, industry leaders, media, policymakers, Bioworkers, artists and more.

How do I register for Ferment?

We're thrilled you'd like to join us! Ferment is a free (and popular) event so to ensure the best experience for all participants, we have to limit access to registration. If you're already a part of our ecosystem, please look out for an invite soon.

However, if you're new to Ginkgo or Ferment, don't worry! We're excited to welcome newcomers and will be releasing public registration for the event in early 2024. In the meantime, feel free to stay connected with us through Ginkgo's newsletter and social media to get the latest updates and news about the conference.

I can’t make it. Will there be a livestream?

Yes! More details to come.

What are Ferment's accessibility offerings?

Ferment will be held at SoWa Power Station, built to code in 2021, under historic building guidelines of the city. 

Accessibility: The venue has grounded (non-raised) curbs and an accessible elevator.

Lactation Room: There will be a clean, private and comfortable space for lactation at Ferment. Guests should bring their own parts and equipment to pump, and refrigeration will be available.

Dietary Accommodations: Catering throughout the day will include vegetarian, vegan, gluten free and dairy free options.

If there are any specific questions regarding inclusive event notes please get in touch via Ferment@ginkgobioworks.com.

I have more questions!

Please get in touch via Ferment@ginkgobioworks.com.